Neuranics has Secured $700K in Seed Funding

Inflection Point Ventures (IPV) is leading the $700K seed round for the healthcare diagnostics firm Neuranics.

Funding Utilisation

The money raised will go toward clinical validation and technical development, which will help the business move closer to commercial manufacturing after CDSCO licensing.

Read Also - The Money Club has Secured $2.5 Million in a Series A Round Funding 

Neuranics, which was founded in 2021 by Praveen Kumar and Ashutosh Patra, is working on a point-of-care blood analyzer that can use a finger prick sample to get full blood count (CBC) results in less than ten minutes.

With its great efficiency and low maintenance requirements, this primary and emergency-use equipment is revolutionizing the healthcare sector. 

In addition, life-saving therapies for serious illnesses including sepsis, severe anemia, and thrombocytopenia, particularly in dengue patients, can be started right away, guaranteeing rapid and efficient care.

The business has been given a patent, obtained the CDSCO Test License, obtained AIIMS Delhi's Ethical Approval, and is currently advancing through clinical trials.

About Neuranics

Neuranics aims to provide disease diagnosis using our AI-based diagnostic device across the country in the fastest and most affordable way. Our goal is to save millions of lives through early diagnosis, reduce treatment costs, and ease the patient load at large hospitals.

Advertisment

Latest Startup Funding News: Your Gateway to Every Funding Update.

Today's Latest Startup News: Stay updated with the latest startup news and trends. Your go-to source for startup ecosystem updates.

Inspiring Startup Stories: Discover inspiring tales of startups overcoming challenges and achieving success.